Yanling Ren

10PUBLICATIONS
22CO-AUTHORS
AutoimmunityMedical mycologyMedical infection agents (incl. prions)Cellular immunologyGene and molecular therapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Feb 11, 2026
Early-onset de novo donor-specific anti-HLA antibodies may contribute to poor graft function following haploidentical transplantation for myelodysplastic syndrome: a rare case presentation.

Xianbo Huang, Xianhui Wu, Shasha Wang

|Feb 03, 2025
Moderate-To-Severe Bone Marrow Fibrosis Is an Independent Risk Factor For Myelodysplastic Neoplasms Patients With Increased Blasts.

Gaixiang Xu, Xingnong Ye, Yudi Zhang

|Apr 17, 2024
RIPK3 deficiency blocks R-2-hydroxyglutarate-induced necroptosis in IDH-mutated AML cells.

Shuanghong Zhu, Yingwan Luo, Kongfei Li

|Feb 16, 2024
Effective management of a rare case of primary renal intravascular large B-cell lymphoma with modified R-CHOP regimen: A case report.

Xianbo Huang, Xianhui Wu, Shasha Wang

|Dec 14, 2022
15-days duration of venetoclax combined with azacitidine in the treatment of relapsed/refractory high-risk myelodysplastic syndromes: A retrospective single-center study.

Chen Mei, Li Ye, Yanling Ren

|Oct 31, 2022
Co-mutation landscape and clinical significance of RAS pathway related gene mutations in patients with myelodysplastic syndrome.

Yanling Ren, Wei Lang, Chen Mei

Pageof 2

Frequent Collaborators

7 joint publications

Xinping Zhou

6 joint publications

Hongyan Tong

5 joint publications

Chen Mei

4 joint publications

Jie Jin